Biotechnology Compass Therapeutics Announces Publication of CTX-8371 Preclinical Data in OncoImmunology, its Bispecific Antibody Checkpoint Inhibitor, now Advancing to First-in-Human Clinical Trial – Compass Therapeutics (NASDAQ:CMPX) Read more
Biotechnology Athira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS) – Athira Pharma (NASDAQ:ATHA) Read more
Biotechnology Madrigal Pharmaceuticals Announces Publication of the Phase 3 MAESTRO-NASH Trial of Resmetirom in the New England Journal of Medicine – Madrigal Pharmaceuticals (NASDAQ:MDGL) Read more
Biotechnology Elicio Therapeutics Announces Publication of Preclinical Data Demonstrating Power Of Amphiphile-Immunotherapy – Elicio Therapeutics (NASDAQ:ELTX) Read more
